These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 23748686)

  • 41. Statins and polyunsaturated fatty acids for treatment of atrial fibrillation.
    Savelieva I; Camm J
    Nat Clin Pract Cardiovasc Med; 2008 Jan; 5(1):30-41. PubMed ID: 18094671
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tracing the origins of postoperative atrial fibrillation: the concept of oxidative stress-mediated myocardial injury phenomenon.
    Elahi MM; Flatman S; Matata BM
    Eur J Cardiovasc Prev Rehabil; 2008 Dec; 15(6):735-41. PubMed ID: 19020458
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of alcohol on atrial fibrillation: myths and truths.
    Balbão CE; de Paola AA; Fenelon G
    Ther Adv Cardiovasc Dis; 2009 Feb; 3(1):53-63. PubMed ID: 19124390
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Therapeutic intent of proton pump inhibitor prescription among elderly nonsteroidal anti-inflammatory drug users.
    Dries AM; Richardson P; Cavazos J; Abraham NS
    Aliment Pharmacol Ther; 2009 Sep; 30(6):652-61. PubMed ID: 19573167
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Novel pharmacological therapies for atrial fibrillation.
    Bagwe S; Leonardi M; Bissett J
    Curr Opin Cardiol; 2007 Sep; 22(5):450-7. PubMed ID: 17762547
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Atrial fibrillation: a perspective: thinking inside and outside the box.
    Wyse DG; Gersh BJ
    Circulation; 2004 Jun; 109(25):3089-95. PubMed ID: 15226225
    [No Abstract]   [Full Text] [Related]  

  • 47. Atrial fibrillation and atrial flutter in athletes.
    Calvo N; Brugada J; Sitges M; Mont L
    Br J Sports Med; 2012 Nov; 46 Suppl 1():i37-43. PubMed ID: 23097477
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevention of new-onset atrial fibrillation and its predictors with angiotensin II-receptor blockers in the treatment of hypertension and heart failure.
    Aksnes TA; Flaa A; Strand A; Kjeldsen SE
    J Hypertens; 2007 Jan; 25(1):15-23. PubMed ID: 17143167
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Postoperative atrial fibrillation.
    Ellenbogen KA; Chung MK; Asher CR; Wood MA
    Adv Card Surg; 1997; 9():109-30. PubMed ID: 9463711
    [No Abstract]   [Full Text] [Related]  

  • 50. Gastroesophageal reflux disease: another risk factor for atrial fibrillation?
    Bamimore A; Budzikowski AS
    Cardiology; 2011; 120(4):185-6. PubMed ID: 22261930
    [No Abstract]   [Full Text] [Related]  

  • 51. Corticosteroids and atrial fibrillation: Risks or benefits?
    Liu T; Li G
    Arch Intern Med; 2006 Sep; 166(16):1785-6. PubMed ID: 16983061
    [No Abstract]   [Full Text] [Related]  

  • 52. Long-Term PPI Use: Balancing Potential Harms and Documented Benefits.
    Laine L; Nagar A
    Am J Gastroenterol; 2016 Jul; 111(7):913-5. PubMed ID: 27113114
    [No Abstract]   [Full Text] [Related]  

  • 53. [Chemotherapy and NSAIDs in neoplastic disease. Role of anti-secretory preventive therapy].
    Annibale B; Panzuto F
    Recenti Prog Med; 2003 Nov; 94(11):473-7. PubMed ID: 14679914
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Drug-induced atrial fibrillation: does it matter?
    Tamargo J; Caballero R; Delpón E
    Discov Med; 2012 Nov; 14(78):295-9. PubMed ID: 23200060
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pathophysiology of atrial fibrillation: current aspects.
    Lammers WJ; Allessie MA
    Herz; 1993 Feb; 18(1):1-8. PubMed ID: 7681026
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of use of proton pump inhibitors in Greece.
    Ntaios G; Chatzinikolaou A; Kaiafa G; Savopoulos C; Hatzitolios A; Karamitsos D
    Eur J Intern Med; 2009 Mar; 20(2):171-3. PubMed ID: 19327607
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Proton pump inhibitors, a family of drugs in continuous expansion].
    Pellicano R
    Minerva Gastroenterol Dietol; 2000 Dec; 46(4):231-41. PubMed ID: 19320085
    [No Abstract]   [Full Text] [Related]  

  • 58. The fibrosis and atrial fibrillation: is the transforming growth factor-beta 1 a candidate etiology of atrial fibrillation.
    Li X; Ma C; Dong J; Liu X; Long D; Tian Y; Yu R
    Med Hypotheses; 2008; 70(2):317-9. PubMed ID: 17689021
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Proton-pump inhibitors are associated with a reduced risk for bleeding and perforated gastroduodenal ulcers attributable to non-steroidal anti-inflammatory drugs: a nested case-control study.
    Vonkeman HE; Fernandes RW; van der Palen J; van Roon EN; van de Laar MA
    Arthritis Res Ther; 2007; 9(3):R52. PubMed ID: 17521422
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevention of atrial fibrillation following cardiac surgery: basis for a novel therapeutic strategy based on non-hypoxic myocardial preconditioning.
    Rodrigo R; Cereceda M; Castillo R; Asenjo R; Zamorano J; Araya J; Castillo-Koch R; Espinoza J; Larraín E
    Pharmacol Ther; 2008 Apr; 118(1):104-27. PubMed ID: 18346791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.